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Bromoform, which is present in drinking
water supplies at low microgram to nano-
gram levels, was tested for its effects on
reproduction and fertility in Swiss CD-1
mice, following the RACB protocol. Data
on body weights, clinical signs, and food
and water consumption from a 2-week
dose-range-finding study (Task 1) were used
to set exposure levels for the Task 2 contin-
uous cohabitation phase at 50, 100, and
200 mg/kg/day by gavage. With a single
exception, dosing formulations were 90 to
110% ofnominal concentrations.
During Task 2 six animals died from
parturition complications, infection, and
skin wounds inflicted by the partner,
which occurred in all dose groups and were
not related to treatment. Water consump-
tion was increased for high dose animals by
approximately 16%. Starting with the first
litter, postpartum dam weights were lower
in the high dose group, compared to con-
trols, by 3 to 8%. Other dose levels, and
male bodyweights, were unaffected.
In Task 2, there were no treatment-
related changes in reproductive end points:
number oflitters per pair, live pups per lit-
ter, viability, and pup bodyweights were all
unaffected by these levels ofbromoform
exposure. The average study day for litter
delivery was not affected by treatment. In
the absence of a reproductive effect to inves-
tigate, no crossover tests wereperformed.
The last litters from all dose groups were
nursed by their dams until weaning.
Bromoform exposure increased neonatal
mortality by 15 to 20% at the high dose
only in the first 4 days postnatally. Pup
body weight was occasionally significantly
reduced in highdose pups prior to weaning.
At weaning, the Fo mice were killed
and discarded without necropsy. Following
the protocol of a "negative" study, at wean-
ing the pups from the low and middle dose
groups were killed and discarded, and the
pups from the control and high dose
groups were reared and dosed through the
mating period (at 74 ± 10 days of age)
until necropsy.
During the F1 mating trial, there were
no differences between the two groups
with respect to mating or fertility index.
The number, viability, and weight of pups
were not affected bybromoform exposure.
After the F2 pups were delivered and
evaluated, the Fl adults were killed and
necropsied. While femalebodyweights were
unaffected by exposure to 200 mg/kg/day
bromoform, relative liver weight was
increased by 8%, and relative kidneyweight
was decreased by 6%. Vaginal cyclicity was
not examined in these mice. In males, body
weights ofthe exposed mice were reduced
by 6%, while weight-adjusted liver weights
were increased by 6% and adjusted kidney
weights were reduced by6%. There were no
changes in other organ weights or in epi-
didymal sperm parameters.
Microscopically, varying degrees of
hepatocellular degeneration was seen in all
treated male and female mice. No treat-
ment-related alterations were noted in kid-
ney, thryoid, lung, or sex organs.
In summary, bromoform caused a slight
increase in postnatal mortality, but no
changes in other reproductive indices, at
doses that caused significant hepatotoxicity.
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Summary: NTP Reproductive Assessment by Continuous Breeding Study.
NTIS#: 89169254/AS
Chemical: Bromoform
CAS#: 75-25-2
Mode of exposure: Gavage
Species/strain: Swiss CD-1 mice
Fegeneration Dose concentration -50mg/kg 100mg/kg 200mg/kg
Bodyweight _ _
Kidneyweight8 _ _ _; ___
Liverweight8
a .
Mortality ___ ___ __
Feedconsumption . . _
Waterconsumption - _ - - '|t
Clinical signs . _ _ __----- _- - _ - _
i litters/pair
# livepups/litter; pupwt./lifter _. - - - -
Cumulativedaystolitter .
Absolutetestis,epididymisweight8 __._
Sexaccessoryglandweight8(prostate, seminal vesicle)
Epidid.spermparameters (I,motility, morphology)
Estrouscyclelength . . * .. _. _ . _
Determination ofaffected sex(crossover) Male Female Both
Dose level __ ________ _.
F, generation Dose concentration - _ 200mg/k
Pupgrowthtoweaning , _
Mortality _ t,t
Adultbodyweight * * 4.
Kidneyweight8 --- _ 4-4
Liverweight8 _ ._ t t
Feed consumption _
Waterconsumption - -
Clinical signs _ -- -- _ = _ _ _
Fertility index - | _ * | _ _ -] _
#live_pups/litter; pupwt./litter I . I . I _ I Absolutetestis,_epididymisweight'"____________ ____________ ____________
Sexaccessoryglandweight8(prostate,_seminal_vesicle) _ * . ,
Epidid. spermparameters(#,motility,morphology) _ *
_ _ -
Estrous_cycle_length _ _. _ __.
Affected sex? Unclear
Studyconfounders: None
NOAELreproductive toxicity: 200mg/kg
NOAELgeneral toxicity: <200mg/kg
F1 moresensitivethanFo? Unclear
Postnatal toxicity: Yes
Legend:-, no change; *, no observation; T or 41, statistically significant change (p<0.05); , , no change in males orfemales. 'Adjusted for bodyweight.
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